Company: NDRA
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001213900-25-110887
Chunk: 161

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-11-14
Form: 10-Q
Item: Part I, Item 2
Chunk 161
---
8-K, filed with the SEC on October 15, 2025)
  
    31.1
     
    Certification of Periodic Report by Principal Executive Officer pursuant to Rule 13a-14(a)/15d-14a and pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith)
  
    31.2
     
    Certification of Periodic Report by Principal Financial Officer pursuant to Rule 13a-14(a)/15d-14a and pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith)
  
    32.1
     
    Certification of Periodic Report by Principal Executive Officer and Principal Financial Officer pursuant to U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith)

    101.INS
     
    XBRL Instance Document (filed herewith)
  
    101.SCH
     
    XBRL Taxonomy Schema (filed herewith)
  
    101.CAL
     
    XBRL Taxonomy Extension Calculation Linkbase (filed herewith)
  
    101.DEF
     
    XBRL Taxonomy Extension Definition Linkbase (filed herewith)
  
    101.LAB
     
    XBRL Taxonomy Extension Label Linkbase (filed herewith)
  
    101.PRE
     
    XBRL Taxonomy Extension Presentation Linkbase (filed herewith)

    104
     
    Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

*Indicates management compensatory plan, contract or arrangement.

**Certain information has been omitted from the exhibit pursuant
to Item 601(b)(10) of Regulation S-K.

30

SIGNATURES

Pursuant to the requirements of Section 13 or
15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.

    ENDRA LIFE SCIENCES INC.

    Date: November 14, 2025
    By: 
    /s/ Alexander Tokman

    Alexander Tokman

    Chief Executive Officer and Chairman

    (Principal Executive Officer)

    ENDRA LIFE SCIENCES INC.

    Date: November 14, 202